EDGAR Filing Documents for 0000819050-22-000087

Form PRE 14A - Other preliminary proxy statements:

SEC Accession No. 0000819050-22-000087

Filing Date

2022-05-27

Accepted

2022-05-27 08:58:45

Documents

Period of Report

2022-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14A	a20220527pre-14a.htm	PRE 14A	231088
2		bbilogohr2021.jpg	GRAPHIC	71984
3		computer.jpg	GRAPHIC	3083
4		i2.jpg	GRAPHIC	224942
5		i3.jpg	GRAPHIC	42660
6		i4.jpg	GRAPHIC	354508
7		i5.jpg	GRAPHIC	138008
8		i6.jpg	GRAPHIC	144912
9		i7.jpg	GRAPHIC	41817
10		i8.jpg	GRAPHIC	330345
11		ii1.jpg	GRAPHIC	149591
12		ml.jpg	GRAPHIC	3585
13		tel.jpg	GRAPHIC	3575
	Complete submission text file	0000819050-22-000087.txt		2311407

Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301

Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755

Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)